Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution

Plain-language summary

This study examines the clinical features and long-term course of familial hypocalciuric hypercalcemia. It enrolled patients with clinical and biochemical suspicion of the condition who had genetic test results available. It was a non-phased, observational study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Intervention

Observational study. No intervention is performed

Start date

2/1/2021

Estimated completion

4/1/2023

Countries

Spain

Related genes

Locations

• Barcelona, Spain

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients with clinical and biochemical suspicion of FHH who, at the discretion of the physician in routine clinical practice, were asked to perform a genetic evaluation of FHH and whose genetic results are available.

Exclusion Criteria:

* Genetic study of FHH is not available or was not performed despite clinical and biochemical suspicion of FHH.